A Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023) reported that participants receiving higher doses of retatrutide (up to 12 mg) achieved mean body weight reductions of approximately 1724% over 48 weeks
Meaningful drug activity persists for 2 to 3 weeks after the last injection
Neurology International (2022) Bremelanotide for Female HSDD (mechanism and usage) Safarinejad, M.R., et al
What you're actually paying for at $199 per month through Omzo: the telehealth consultation, the licensed clinician's review of your health history, the compounded medication prepared by a pharmacy, and shipping
Insulin is released: While you are eating, GLP-1 allows the body to release more insulin, decreasing blood sugar levels and balancing your blood glucose
Sang Kwon, Jong Eun Yeon, Soon Koo Baik Journal of Gastroenterology and Hepatology .2026